Attributes | Values |
---|
rdf:type
| |
Description
| - An X-ray structure (resolution 2.2 A) of mutant HIV-1 protease (A71V, V82T, 184V) complexed with newly developed peptidomimetic inhibitor with ethyleneamine isostere Boc-Phe-.PSI.[CH2CH2NH]/Phe/Glu/Phe/NH2, denoted as OE, is described and compared with the complex of wild type HIV/1 protease with the same inhibitor (resolution 2.5 A). In the mutant protease weaker van der Waals interactions of the mutated residues Val 84 and Val 184 with OE were found. This lack of interaction energy is compensated by a new aromatic hydrogen bond between phenyl ring of the inhibitor in position P1 and the mutated residue Thr 182.
- An X-ray structure (resolution 2.2 A) of mutant HIV-1 protease (A71V, V82T, 184V) complexed with newly developed peptidomimetic inhibitor with ethyleneamine isostere Boc-Phe-.PSI.[CH2CH2NH]/Phe/Glu/Phe/NH2, denoted as OE, is described and compared with the complex of wild type HIV/1 protease with the same inhibitor (resolution 2.5 A). In the mutant protease weaker van der Waals interactions of the mutated residues Val 84 and Val 184 with OE were found. This lack of interaction energy is compensated by a new aromatic hydrogen bond between phenyl ring of the inhibitor in position P1 and the mutated residue Thr 182. (en)
|
Title
| - An ethylenamine inhibitor binds tightly to both wild type and mutant HIV-1 proteases. Structure and energy study.
- An ethylenamine inhibitor binds tightly to both wild type and mutant HIV-1 proteases. Structure and energy study. (en)
|
skos:prefLabel
| - An ethylenamine inhibitor binds tightly to both wild type and mutant HIV-1 proteases. Structure and energy study.
- An ethylenamine inhibitor binds tightly to both wild type and mutant HIV-1 proteases. Structure and energy study. (en)
|
skos:notation
| - RIV/61389013:_____/03:55033128!RIV/2004/AV0/A55004/N
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(GA203/00/D117), P(GA204/00/P091), P(GV203/98/K023), P(IAA4050811), P(KJB4050312), P(NI6339), Z(AV0Z4050913), Z(AV0Z4055905), Z(MSM 113100001)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61389013:_____/03:55033128
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - mutant HIV-1 protease; ethylenamine inhibitor; structure (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Journal of Medicinal Chemistry
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...ocetUcastnikuAkce
| |
http://linked.open...nichUcastnikuAkce
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Dohnálek, Jan
- Dušková, Jarmila
- Hašek, Jindřich
- Konvalinka, Jan
- Souček, Milan
- Skálová, Petra
- Jeřábková, Hana
- Buchtelová, Eva
- Majer, Pavel
- Uhlíková, Taťána
|
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |